DOCSLIB.ORG

Regitration Files I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regitration Files I LIST OF REGISTRATION FILES IN THE OFFICE OF THE PTO-3 CIRCLE, BANGALORE & INFORMATION UNDER SECTION 4(1)(A) OF THE RIGHT TO INFORMATION ACT 2005 Sl.No. FILE NO Name of the Tax Payer Year of Date of Category ABCDE Date Name of the Official who has sent Date on which the file is received Name of the Officer incharge of Rack Bundle Year Year of Date of Name Name opening the closing the on the file to the record Room in the record Room Record Room No No disposa destruc of of file file which l tion of Officer officer the file the who who is sent record has has to ordered destroy record for ed the Room destruc record tion of the 1 361141220 I C F A I BUSINESS SCHOOL 10-01-2007 CONTINUED A MALLIKARJUN, FDA 2 345152479 I CODE TECHNOLOGIES PVT.LTD 04-01-2010 CONTINUED A MALLIKARJUN, FDA 3 363131313 I D B I BANK LTD. 22/07/1997 CONTINUED A MALLIKARJUN, FDA 4 367132160 I G L PRIMARY SCHOOL 29/01/1981 CONTINUED A MALLIKARJUN, FDA 5 369129916 I LOGICON INFOR SYSTEMS P.LTD 28/05/2007 CONTINUED A MALLIKARJUN, FDA 6 350151331 I M C OF GOVT. I T I (VIVEK NAGAR) 09-07-2009 CONTINUED A MALLIKARJUN, FDA 7 306180038 I NUBE SOFTWARE SOLUTION PVT.LTD. 11-01-2010 CONTINUED A MALLIKARJUN, FDA 8 377150719 I TRANS TECHNOLOGIES (INDIA) PVT.LTD 09-01-2009 CONTINUED A MALLIKARJUN, FDA 9 360148453 I TRUST INFORMATICS PVT.LTD 11-01-2008 CONTINUED A MALLIKARJUN, FDA 10 383131765 I WAVE SYSTEMS TECHNOLGY P LTD 09-03-1999 CONTINUED A MALLIKARJUN, FDA 11 361148980 I2BI IT CONSULTING PVT.LTD 29/10/2008 CONTINUED A MALLIKARJUN, FDA 12 366148511 I-ADMIN OUTSOURCING PVT.LTD 03-01-2009 CONTINUED A MALLIKARJUN, FDA 13 375149083 IBM INDIA PVT.LTD. 12-11-1997 CONTINUED A MALLIKARJUN, FDA 14 307129834 IBS FINTECH INDIA P.LTD 25/07/2007 CONTINUED A MALLIKARJUN, FDA 15 382132305 ICAD SOFTWARE SERVICES (P) LTD 18/02/2003 CONTINUED A MALLIKARJUN, FDA 16 379149930 ICEBERG FOODS LTD 04-01-2005 CONTINUED A MALLIKARJUN, FDA 17 387152400 ICFAI REPUBLIC SCHOOL 02-01-2010 CONTINUED A MALLIKARJUN, FDA 18 385152607 ICICI BANK LTD. 04-01-2010 CONTINUED A MALLIKARJUN, FDA 19 319132472 IDBI BANK LTD. 23/03/1999 CONTINUED A MALLIKARJUN, FDA 20 332148247 IDBI CAPITAL MARKET SERVICES LTD. 06-01-2008 CONTINUED A MALLIKARJUN, FDA 21 361401374 IDBI FORTIS LIFE INSURANCE CO LTD 04-10-2009 CONTINUED A MALLIKARJUN, FDA 22 394151433 IDBI FORTIS LIFE INSURANCE CO LTD 04-10-2009 CONTINUED A MALLIKARJUN, FDA 23 324149269 IDBI INTECH LTD 02-01-2008 CONTINUED A MALLIKARJUN, FDA 24 395141484 IDEAL INVENT TECHNOLOGIES P.LTD 28/03/2006 CONTINUED A MALLIKARJUN, FDA 25 359148993 IDEAON SOFTWARE CONSULTANCY PVT.LTD 07-01-2008 CONTINUED A MALLIKARJUN, FDA 26 335152350 IDEXCEL TECHNOLOGIES PRIVATE LIMITED 07-01-2009 CONTINUED A MALLIKARJUN, FDA 27 390150198 IDG MEDIA PRIVATE LIMITED 14/09/2005 CONTINUED A MALLIKARJUN, FDA 28 386120348 IGS IMAGING SERVICES (INDIA) PVT.LTD. 29/06/2001 CONTINUED A MALLIKARJUN, FDA 29 334131065 I-LOGICON CONTROL AUTOMATION P LTD 16/07/2004 CONTINUED A MALLIKARJUN, FDA 30 345133370 IMAGE LABELS PVT LTD 04-01-1999 CONTINUED A MALLIKARJUN, FDA 31 349130240 IMAGO SYSTEM 15/07/2006 CONTINUED A MALLIKARJUN, FDA 32 385388414 IMG DEVELOPERS 17/08/2007 CONTINUED A MALLIKARJUN, FDA 33 325130008 IMOBIXX 19/02/2007 CONTINUED A MALLIKARJUN, FDA IMPERIAL CANCER HOSPITAL & RESEARCH CENTRE 34 321130228 P.LTD 08-07-2006 CONTINUED A MALLIKARJUN, FDA 35 310161776 IMPERIAL ELECTRO CONTROLS PVT.LTD. 07-01-2007 CONTINUED A MALLIKARJUN, FDA 36 398151795 IMT SPECIALISTS PVT.LTD 04-01-2007 CONTINUED A MALLIKARJUN, FDA 37 369141750 IN FORM ARCHITECTS PVT.LTD. 08-07-1998 CONTINUED A MALLIKARJUN, FDA 38 369133699 INCHARA FAMILY GARDEN RESTAURENT 12-01-2000 CONTINUED A MALLIKARJUN, FDA 39 345148793 INCICON-AG 09-01-2006 CONTINUED A MALLIKARJUN, FDA 40 384149461 INDAIRCON ENGINEERS PVT.LTD 04-09-2009 CONTINUED A MALLIKARJUN, FDA 41 344146811 INDIA FINSOL PVT.LTD 10-01-2008 CONTINUED A MALLIKARJUN, FDA 42 325180351 INDIA FIRST LIFE INSURANCE COMPANY LTD 09-02-2010 CONTINUED A MALLIKARJUN, FDA 43 346142142 INDIA HERITAGE FOUNDATION 24/05/2006 CONTINUED A MALLIKARJUN, FDA 44 316131958 INDIA MOTOR PARTS & ACCESSORIES PVT.LTD. 10-10-1984 CONTINUED A MALLIKARJUN, FDA 45 332150963 INDIAN BANK 04-01-1987 CONTINUED A MALLIKARJUN, FDA 46 359152291 INDIAN BANK J.P.NAGAR BRANCH 21/06/2006 CONTINUED A MALLIKARJUN, FDA 47 320130089 INDIAN FASHIONS MARKETING P.LTD 13/12/2006 CONTINUED A MALLIKARJUN, FDA 48 340128989 INDIAN INSTITUTE OF MANAGEMENT BANGALORE 06-05-1976 CONTINUED A MALLIKARJUN, FDA 49 371133007 INDIAN OVERSEAS BANK 04-01-1978 CONTINUED A MALLIKARJUN, FDA 50 313388494 INDIAN OVERSEAS BANK 04-01-2003 CONTINUED A MALLIKARJUN, FDA 51 380130766 INDIAN OVERSEAS BANK 07-12-2005 CONTINUED A MALLIKARJUN, FDA 52 375138510 INDIAN OVERSEAS BANK 24/06/2008 CONTINUED A MALLIKARJUN, FDA 53 323141564 INDIAN PRINTERS&PUBLISHERS 03-05-2004 CONTINUED A MALLIKARJUN, FDA 54 393125298 INDIEN HILFE 01-01-1991 CONTINUED A MALLIKARJUN, FDA 55 346179487 INDIRA FOODS 05-04-2010 CONTINUED A MALLIKARJUN, FDA 56 321133817 INDIRA GANDHI INSTITUTE OF CHILD HEALTH 06-08-1994 CONTINUED A MALLIKARJUN, FDA INDIRA GANDHI NATIONAL OPEN UNIVERSITY(BLORE 57 353150293 REGIONAL CENTRE) 12-09-2005 CONTINUED A MALLIKARJUN, FDA 58 331133073 INDIRA PRIYADARSHINI GIRLS HIGH SCHOOL 02-02-1977 CONTINUED A MALLIKARJUN, FDA 59 376130113 INDIUM DEVELOPMENT P.LTD 29/11/2006 CONTINUED A MALLIKARJUN, FDA 60 384147715 INDIVIBE ENTERTAINMENT PVT.LTD 01-05-2007 CONTINUED A MALLIKARJUN, FDA 61 353147189 INDO ARYA CENTRAL TRANSPORT 23/10/1980 CONTINUED A MALLIKARJUN, FDA 62 365400572 INDO DUCH PROJECT MANG SOCIETY (IDPMS) 22/03/1989 CONTINUED A MALLIKARJUN, FDA 63 320131544 INDTECH APPERALS (P) LTD 04-01-2004 CONTINUED A MALLIKARJUN, FDA 64 316131376 INDU STEELS & ALLOYS PVT LTD 07-10-1996 CONTINUED A MALLIKARJUN, FDA 65 377131707 INDUS CORP INDIA P LTD 08-01-2001 CONTINUED A MALLIKARJUN, FDA 66 382145885 INDUS TOWERS LTD 04-01-2008 CONTINUED A MALLIKARJUN, FDA 67 335139255 INDUS WEST SIDE HEALTH CARE PVT LTD 23/08/2007 CONTINUED A MALLIKARJUN, FDA 68 331131424 INDUSTRIAL CONVERTERS 22/02/1996 CONTINUED A MALLIKARJUN, FDA 69 390382222 INDYGO SOFTWARE SYSTEMS PVT.LTD. 26/04/2007 CONTINUED A MALLIKARJUN, FDA 70 380131639 INFOBASE (I) DEVELOPMENT CENTRE P LTD 11-01-2002 CONTINUED A MALLIKARJUN, FDA 71 347129089 INFOCON INTERNATIONAL LTD 08-01-1992 CONTINUED A MALLIKARJUN, FDA 72 366152585 INFOMAP BPO SERVICES (INDIA) PVT.LTD 09-11-2006 CONTINUED A MALLIKARJUN, FDA 73 367130511 INFOMAP CONSULTANT P.LTD 17/10/2006 CONTINUED A MALLIKARJUN, FDA 74 346130696 INFONICS SOFTWARE PVT.LTD. 24/10/2005 CONTINUED A MALLIKARJUN, FDA INFORMATION DATA ACQUISITION AND CONTROL 75 395146819 SOLUTIONS INDIA PVT.LTD 07-02-2008 CONTINUED A MALLIKARJUN, FDA 76 364147942 INFOSPAN TECHNOLOGIES PVT.LTD 11-01-2008 CONTINUED A MALLIKARJUN, FDA 77 339130596 INFOVALLEY BIO SYSTEMS (IND) P.LTD 25/01/2006 CONTINUED A MALLIKARJUN, FDA 78 395138865 INNISFREE HOUSE SHOOL 12-09-1998 CONTINUED A MALLIKARJUN, FDA 79 389152678 INNOTECH ENGINEERING CONSULT PVT.LTD. 04-12-2010 CONTINUED A MALLIKARJUN, FDA 80 333131120 INNOVATION INSTITUTE OF MEDICAL TRANSCRIPTION 07-03-2003 CONTINUED A MALLIKARJUN, FDA 81 394181212 INNOVATIVE INSTITUTES NETWORK TECHNOLOGY 08-01-2010 CONTINUED A MALLIKARJUN, FDA 82 381120041 INNOVER SANT SOLUTIONS PVT. LTD. 05-01-2008 CONTINUED A MALLIKARJUN, FDA 83 389141620 INNOVLITE (INDIA) P.LTD 03-02-2007 CONTINUED A MALLIKARJUN, FDA 84 371130582 INOTECH SUPPLIES PVT. LTD. 31/01/2006 CONTINUED A MALLIKARJUN, FDA 85 319179905 I-NOVATE TECHNOLOGIES LIMITED. 11-01-2010 CONTINUED A MALLIKARJUN, FDA INOX LEISURE LTD.,(INOX MULTIPLEX GARUDA 86 324149754 SWAGATH MALL) 11-01-2007 CONTINUED A MALLIKARJUN, FDA INSPIRARE STRATEGIC MANAGEMENT SOLUTIONS 87 319161766 PVT.LTD. 06-01-2010 CONTINUED A MALLIKARJUN, FDA 88 361148786 INSPIRATION MAN POWER CONSULTANCY PVT.LTD 04-01-2009 CONTINUED A MALLIKARJUN, FDA 89 309150288 INSTACOMM SOLUTIONS (BANGALURU) PVT.LTD. 07-01-2009 CONTINUED A MALLIKARJUN, FDA 90 342179998 INSTANCE SOFTECH PVT, LTD. 04-01-2009 CONTINUED A MALLIKARJUN, FDA 91 319142463 INSTITUTE FOR TECHNO & MANAGEMENT 16/06/2004 CONTINUED A MALLIKARJUN, FDA 92 380151621 INTECH APPARELS 04-01-2009 CONTINUED A MALLIKARJUN, FDA 93 312129753 INTECH GARMENT PROCESSORS 26/09/2007 CONTINUED A MALLIKARJUN, FDA 94 340138204 INTEGRETTI HRES SOLUTIONS PVT LTD 08-01-2008 CONTINUED A MALLIKARJUN, FDA 95 302152322 INTERBRANDS BEVERAGES PVT.LTD. 10-01-2009 CONTINUED A MALLIKARJUN, FDA 96 379131888 INTERIOR CONSULTANTS PVT LTD 04-01-1987 CONTINUED A MALLIKARJUN, FDA 97 374146616 INTERNATIONAL BUSINESS SCHOOL 12-12-2007 CONTINUED A MALLIKARJUN, FDA 98 325124382 INTERNATIONAL MARKETING CORPN. 30/07/1990 CONTINUED A MALLIKARJUN, FDA 99 329179064 INTEX TECHNOLOGIES (INDIA) LIMITED. 04-01-2004 CONTINUED A MALLIKARJUN, FDA 100 339131663 INVENSOFT TECHNOLOGIES P LTD 04-01-2002 CONTINUED A MALLIKARJUN, FDA 101 313150068 ION EXCHANGE INDIA LTD 04-01-2005 CONTINUED A MALLIKARJUN, FDA 102 393150421 IP FONLINE LTD 30/05/2001 CONTINUED A MALLIKARJUN, FDA 103 363131895 IPCA LABORATORIES P LTD 04-01-1984 CONTINUED A MALLIKARJUN, FDA 104 324142091 IQ ENGINEERING (INDIA) PVT.LTD. 04-01-2005 CONTINUED A MALLIKARJUN, FDA 105 372151673 IQURA TECHNOLOGIES PVT.LTD. 04-01-2000 CONTINUED A MALLIKARJUN, FDA 106 382147437 ISOLVE TECHNOLOGIES PVT.LTD 04-01-2008 CONTINUED A MALLIKARJUN, FDA 107 376388424 ISOMETRIC SOLUTIONS. 16/01/2007 CONTINUED A MALLIKARJUN, FDA 108 373125428 I-SOURCE INFO SYSTEMS PVT LTD 20/11/2004 CONTINUED A MALLIKARJUN, FDA 109 395147595 ISOURCE WORLDWIDE (INDIA) PVT.LTD 12-01-2008 CONTINUED A MALLIKARJUN, FDA 110 377388369 IT ABODE 18/04/2007 CONTINUED A MALLIKARJUN, FDA 111 367161745 IT SEERS SOFTWARE PVT.LTD.
Load more

Recommended publications
  • Update on Equity Stake in Indus Towers
    1 September 2020 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Phiroze Jeejeebhoy Bandra - Kurla Complex, Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Dear Sirs, Sub: Update on Bharti Infratel and Indus Towers Merger Ref: Vodafone Idea Limited (the “Company”) (IDEA / 532822) Further to our communication dated 24 June 2020 in relation to the merger of Indus Towers Limited (in which the Company is holding 11.15% equity stake) with Bharti Infratel Limited (“Merger”), please find attached a press release titled “Update on Bharti Infratel and Indus Towers Merger”, being issued to media. The above is for your information and dissemination to the members. Thanking you, Yours truly, For Vodafone Idea Limited Pankaj Kapdeo Company Secretary Encl: As above Vodafone Idea Limited (formerly Idea Cellular Limited) An Aditya Birla Group and Vodafone partnership Birla Centurion, 9th to 12th Floor, Century Mills Compound, Pandurang Budhkar Marg, Worli, Mumbai – 400 030. T: +91 95940 04000F: +91 22 2482 0093 www.vodafoneidea.com Registered Office: Suman Tower, Plot no. 18, Sector 11, Gandhinagar – 382 011, Gujarat. T +91 79 6671 4000 F +91 79 2323 2251 CIN: L32100GJ1996PLC030976 Media Release – September 01, 2020 Update on Bharti Infratel and Indus Towers Merger Vodafone Idea Limited (“VIL”), Vodafone Group Plc (“Vodafone”), Bharti Airtel Limited (“Bharti Airtel”), Indus Towers Limited (“Indus”) and Bharti Infratel Limited (“Infratel”) (collectively referred as “Parties” and individually as “Party”) have agreed to proceed with completion of the merger of Indus and Infratel. VIL has undertaken to sell its 11.15% stake in Indus for cash.
    [Show full text]
  • Copy of TP-Concession to Customers R Final 22.04.2021.Xlsx
    TECHNOPARK-BENEFITS TO NON-IT ESTABLISHMENTS Name of the Company 6 Months 3 Months Esclation Total Akshaya (Kerala State IT Mission) 1,183.00 7,332.00 488.00 9,003.00 A V Hospitalities ( Café Elisa) 1,97,463.00 1,08,024.00 16,200.00 3,21,687.00 Bharti Airtel Ltd 1,50,000.00 75,000.00 15,000.00 2,40,000.00 Bharath Sanchar Nigam Ltd (BSS Mobile) 3,14,094.00 1,57,047.00 31,409.00 5,02,550.00 Bharti Airtel Ltd (Bharti Tele-Ventures Ltd (Broad band) 26,622.00 13,311.00 2,662.00 42,595.00 BEYOND THE LIMITS 3,21,097.00 - - 3,21,097.00 Fire In the Belly Café L.L.P (Buraq Space) 4,17,066.00 2,08,533.00 41,707.00 6,67,306.00 HDFC Bank Ltd (ATM) 1,50,000.00 75,000.00 15,000.00 2,40,000.00 Indus Towers Limited [Bharti Tele-Ventures Ltd (Mobile-Airtel) Bharti Infratel Ventures Ltd] 3,40,524.00 1,70,262.00 34,052.00 5,44,838.00 ICICI Bank Ltd 1,50,000.00 75,000.00 15,000.00 2,40,000.00 Indus Towers Limited 1,46,604.00 73,302.00 14,660.00 2,34,566.00 Idea Cellular Limited 1,50,000.00 75,000.00 15,000.00 2,40,000.00 JODE's Cake World 1,47,408.00 73,704.00 14,741.00 2,35,853.00 The Kerala State Women's Development Corporation Limited 1,67,742.00 83,871.00 16,774.00 2,68,387.00 RAILTEL Corporation of India Ltd 13,008.00 6,504.00 1,301.00 20,813.00 State Bank of India, ATM 1,50,000.00 75,000.00 15,000.00 2,40,000.00 SS Hospitality Services 2,81,190.00 1,40,595.00 28,119.00 4,49,904.00 Sr.Superintendent of Post Office 6.00 3.00 - 9.00 ATC Telecom Infrastructure (P) Limited (VIOM Networks Ltd (Wireless TT Info Services Ltd, Tata Tele Services Ltd) 3,41,136.00
    [Show full text]
  • Marketgrader India All-Cap Growth Leaders Index
    Fact Sheet MarketGrader MarketGrader India All-Cap Growth Leaders Index RESEARCH & INDEXES The MarketGrader India All-Cap Growth Leaders Index consists of the 80 most fundamentally sound companies with the best growth prospects in India, whose shares are listed in the country’s national exchanges or in the United States. Its objective is to give investors access to the best companies in the world’s fastest growing large economy without overpaying for their shares. Constituents are selected across all market cap segments and all economic sectors after they have passed rigorous size and liquidity filters. Index Rules Performance Investable Universe CumulativeIndia Growth Leaders Total Return, Jan. 2008 - Jul. 2021 All data as of July 30, 2021 All companies domiciled in India that have 175% received a MarketGrader Score consistently for at least six months, whose shares are 150% listed on the National Stock Exchange, the 125% Bombay Stock Exchange or on U.S. national 100% exchanges. 75% Regulatory Requirements 50% Stocks are ineligible for Index selection if 25% they are included in the ‘Red Flag List,’ 0% maintained and published by the National Securities Depository Limited (NDSL) of India, -25% or on the ‘Breach List,’ maintained by the -50% Central Depository Services (India) Limited 07/30/21 -75% (CDSL), both of which govern foreign own- 12/31/07 12/31/08 12/31/09 12/31/10 12/30/11 12/31/12 12/31/13 12/31/14 12/31/15 12/30/16 12/29/17 12/31/18 12/31/19 12/31/20 ership limits of Indian securities.
    [Show full text]
  • Ind Us TOWERS July 29, 2021
    ind us TOWERS July 29, 2021 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block -G, Bandra Kurla Complex, Dalal Street, Mumbai-400001 Bandra (E), Mumbai-400051 Ref: Indus Towers Limited (534816 I INDUSTOWERl Sub: Press Release w.r.t. audited financial results for the first quarter (Ql) ended June 30, 2021 Dear Sir/ Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the press release being issued by the Company with regard to the audited financial results of the Company for the first quarter (QI) ended June 30, 2021. Kindly take the same on record. Thanking you, Yours faithfully, For Indus Towers Limited (formerly Bharti Infratel Limited) Samridhi Rodhe Company Secretary Encl: As above Indus Towers Limited (formerly Bharti lnfratel Limited) Corporate Office: Building No. 10, Tower A, 4th Floor, DLF Cyber City, Gurugram-122002, Haryana I Tel: +91 -124-4296766 Fax: +91124 4289333 Registered Office: 901, Park Centra, Sector 30, NH-8, Gurugram - 122001, Haryana I Tel: +91 -124-4132600 Fax: +91124 4109580 CIN: L64201 HR2006PLC073821 I Email: compliance.officer@industowers com I www.industowers.com Indus Towers Limited – Media Release July 29, 2021 Indus Towers Limited (Formerly Bharti Infratel Limited) Indus Towers announces Consolidated results for the first quarter ended June 30, 2021 Consolidated Revenues for the quarter at Rs. 6,797 Crore, up 12% Y-o-Y Consolidated EBITDA for the quarter at Rs. 3,529 Crore, up 13% Y-o-Y Consolidated Profit after Tax for the quarter at Rs.
    [Show full text]
  • Investor Presentation – Proposed Merger with Indus Towers
    Proposed Merger with Indus Towers Dec 2018 Disclaimer By attending the meeting where this presentation is made, or by reading the presentation materials, you agree to be bound by the following limitations: The information in this presentation has been prepared by Bharti Infratel Limited (the “Company”) for use in presentations by the Company at investor meetings and does not constitute a recommendation regarding the securities of the Company. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information, or opinions contained herein. Neither the Company nor any of its advisors or representatives shall have any responsibility or liability whatsoever (for negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. The information set out herein may be subject to updating, completion, revision, verification and amendment and such information may change materially. Neither the Company nor any of its advisors or representatives is under any obligation to update or keep current the information contained herein. The information communicated in this presentation contains certain statements that are or may be forward looking. These statements typically contain words such as "will", "expects" and "anticipates" and words of similar import. By their nature forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. These risks include regulatory approvals that may require acceptance of conditions with potentially adverse impacts; the parties’ respective ability to realize expected benefits associated with the transaction; the impact of legal or other proceedings; and continued growth in the market for telecommunications services and general economic conditions in the relevant market(s).
    [Show full text]
  • Momentum Pick
    Momentum Picks Open Recommendations New recommendations Gladiator Stocks Date Scrip I-Direct Code Action Initiation Range Target Stoploss Duration 1-Oct-21 Nifty Nifty Sell 17520-17545 17482/17430 17583.00 Intraday Scrip Action 1-Oct-21 ONGC ONGC Buy 142.50-143.00 144.25/145.70 141.20 Intraday Hindalco Buy PICK MOMENTUM 1-Oct-21 UPL UPL Sell 707.00-708.00 700.60/693.80 714.60 Intraday Bata India Buy 30-Sep-21 Trent TRENT Buy 1010-1025 1125 948.00 30 Days HDFC Buy 30-Sep-21 Dhampur Sugar DHASUG Buy 290-294 312 282.00 07 Days Duration: 3 Months Click here to know more… Open recommendations Date Scrip I-Direct Code Action Initiation Range Target Stoploss Duration 29-Sep-21 SJVN SJVLIM Buy 28.3-29 31.50 27.00 14 Days 29-Sep-21 National Aluminium NATALU Buy 92-94 101.00 86.50 07 Days Intraday recommendations are for current month futures. Positional recommendations are in cash segment Retail Equity Research Retail – October 1, 2021 For Instant stock ideas: SUBSCRIBE to mobile notification on ICICIdirect Mobile app… Research Analysts Securities ICICI Dharmesh Shah Nitin Kunte, CMT Ninad Tamhanekar, CMT [email protected] [email protected] [email protected] Pabitro Mukherjee Vinayak Parmar [email protected] [email protected] NSE (Nifty): 17618 Technical Outlook NSE Nifty Daily Candlestick Chart Domestic Indices Day that was… Open High Low Close Indices Close 1 Day Chg % Chg Equity benchmarks concluded the monthly expiry session on a subdued note tracking mixed global cues.
    [Show full text]
  • FTSE India 30/18 Capped
    2 FTSE Russell Publications 19 August 2021 FTSE India 30/18 Capped Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country 3M India 0.1 INDIA Glenmark Pharmaceuticals 0.14 INDIA Oil India Ltd 0.07 INDIA ABB India 0.13 INDIA GMR Infrastructure 0.1 INDIA Oracle Financial Services Software 0.12 INDIA ACC 0.24 INDIA Godrej Consumer Products 0.45 INDIA Page Industries 0.24 INDIA Adani Enterprises 0.57 INDIA Godrej Industries 0.07 INDIA Petronet LNG 0.24 INDIA Adani Gas 0.4 INDIA Godrej Properties 0.18 INDIA PI Industries 0.3 INDIA Adani Green Energy 0.63 INDIA Grasim Industries 0.82 INDIA Pidilite Industries 0.47 INDIA Adani Ports and Special Economic Zone 0.77 INDIA Gujarat Gas 0.19 INDIA Piramal Enterprises 0.41 INDIA Adani Power 0.15 INDIA Havells India 0.34 INDIA Power Finance 0.21 INDIA Aditya Birla Capital 0.08 INDIA HCL Technologies 1.52 INDIA Power Grid Corp of India 0.78 INDIA Alkem Laboratories 0.11 INDIA HDFC Asset Management 0.27 INDIA Punjab National Bank 0.06 INDIA Ambuja Cements 0.33 INDIA HDFC Life Insurance Company 0.63 INDIA Rajesh Exports 0.11 INDIA Apollo Hospitals Enterprise 0.51 INDIA Hero MotoCorp 0.54 INDIA RBL Bank 0.13 INDIA Ashok Leyland 0.25 INDIA Hindalco 0.75 INDIA REC 0.2 INDIA Asian Paints 1.92 INDIA Hindustan Aeronautics 0.05 INDIA Reliance Industries 9.35 INDIA Astral 0.25 INDIA Hindustan Petroleum 0.3 INDIA Reliance Industries - Partly Paid 0.36 INDIA AU Small Finance Bank 0.23 INDIA Hindustan
    [Show full text]
  • Investor Presentation November 2014
    Investor Presentation November 2014 Disclaimer By attending the meeting where this presentation is made, or by reading the presentation materials, you agree to be bound by the following limitations: The information in this presentation has been prepared by Bharti Infratel Limited (the “Company”) for use in presentations by the Company at investor meetings and does not constitute a recommendation regarding the securities of the Company. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information, or opinions contained herein. Neither the Company nor any of its advisors or representatives shall have any responsibility or liability whatsoever (for negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. The information set out herein may be subject to updating, completion, revision, verification and amendment and such information may change materially. Neither the Company nor any of its advisors or representatives is under any obligation to update or keep current the information contained herein. The information communicated in this presentation contains certain statements that are or may be forward looking. These statements typically contain words such as "will", "expects" and "anticipates" and words of similar import. By their nature forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Any investment in securities issued by the Company will also involve certain risks. There may be additional material risks that are currently not considered to be material or of which the Company and its advisors or representatives are unaware.
    [Show full text]
  • REPORT On15th ISQ ANNUAL CONFERENCE 2018
    REPORT ON15th ISQ ANNUAL CONFERENCE 2018 ISQ is happy to announce successful conduct of 15th Annual Conference 2018 on 14-15, December 2018. Delegates from various segments of engineering, service and academia participated in the conference actively. Venue : Holiday Inn, Aerocity, New Delhi Date : 14-15, December 2018 No. of days : 2 No. of delegates :120 Key note Speeches : 9 Case study presentations : 14 Theme : Exponential growth in the industry with the rapid advancement in the connectivity, mobility, analytics, scalability helped by rapid digitalization using big data, machine learning, artificial intelligence, automation, and recent great strides in life sciences are all poised to change the way we live. Through these tools which define Quality 4.0; Quality professionals are expected to make Quality Management Systems to contribute to bottom line of an organization by integrating Quality Process and data to the overall ecosystem, which drives innovations while improving overall quality. The conference is aimed at bringing out the best insight to Quality 4.0 and the road ahead through the address by experts, implementation experiences and challenges faced through case studies from the best of organisations. Hence the theme “Quality 4.0: Preparing for the Digital Age.” Our Sponsors GOLD : SILVER : :: Sponsors : Supporting organisations: ▪ SRF Limited ▪ Mahindra & Mahindra Ltd. ▪ CEAT Limited ▪ Schneider Electric ▪ Sona BLW Precision Forgings Ltd. ▪ Subros Limited ▪ Ashok Leyland ▪ TTK Prestige Limited ▪ DCM Limited ▪ Yuken India Limited ▪ Dayco ▪ TQMI International Pvt. Ltd. ▪ Elgi Equipments ▪ Toluna India Pvt. Ltd. ▪ Mindarika Pvt. Ltd. ▪ JBM Auto Limited ▪ Indus Towers ▪ JTEKT India Limited ▪ Minda Kosei Aluminium Wheels Pvt. ▪ Infosys BPM Limited Ltd.
    [Show full text]
  • Indus Towers Limited (Formerly Bharti Infratel Limited): Ratings Reaffirmed at [ICRA]AA+/A1+; Outlook Revised to Stable from Negative
    April 9, 2021 Revised Indus Towers Limited (formerly Bharti Infratel Limited): Ratings reaffirmed at [ICRA]AA+/A1+; outlook revised to Stable from Negative Summary of rating action Previous Rated Current Rated Instrument* Amount Amount Rating Action (Rs. crore) (Rs. crore) [ICRA]AA+ (Stable); reaffirmed, outlook Issuer Rating - - revised to Stable Commercial Paper 6,000.0 6,000.0 [ICRA]A1+; reaffirmed [ICRA]AA+ (Stable); reaffirmed, outlook Non-Convertible Debentures 2,500.0 2,500.0 revised to Stable [ICRA]AA+ (Stable); reaffirmed, outlook Term Loans 4,000.0 5,000.0 revised to Stable Fund based/Non Fund based [ICRA]AA+ (Stable); reaffirmed, outlook 3,550.0 5,500.0 limits revised to Stable [ICRA]AA+ (Stable)/A1+; reaffirmed, Unallocated limits 3,950.0 1,000.0 outlook revised to Stable Total 20,000.0 20,000.0 *Instrument details are provided in Annexure-1 Rationale ICRA had considered the merged profile of Bharti Infratel Limited (BIL) and Indus Towers Limited (Indus) while assigning the ratings earlier. Further, following the completion of merger between the two entities, the limits from the erstwhile Indus have been transferred to BIL, the merged entity, which was later renamed as Indus Towers Limited (formerly Bharti Infratel Limited) or the company. The revision in rating outlook to Stable factors in the anticipation of sustenance of the financial risk profile of the company through implementation of the security package for the receivables of one of the key tenants. The outlook revision also considers the receipt of a sizeable proportion of the outstanding dues from the same tenant.
    [Show full text]
  • 2021 Semi-Annual Report (Unaudited)
    FEBRUARY 28, 2021 2021 Semi-Annual Report (Unaudited) iShares, Inc. • iShares Core MSCI Emerging Markets ETF | IEMG | NYSE Arca • iShares MSCI BRIC ETF | BKF | NYSE Arca • iShares MSCI Emerging Markets Asia ETF | EEMA | NASDAQ • iShares MSCI Emerging Markets Small-Cap ETF | EEMS | NYSE Arca The Markets in Review Dear Shareholder, The 12-month reporting period as of February 28, 2021 reflected a remarkable period of disruption and adaptation, as the global economy dealt with the implications of the coronavirus (or “COVID-19”) pandemic. As the period began, the threat from the virus was becoming increasingly apparent, and countries around the world took economically disruptive countermeasures. Stay-at-home orders and closures of non-essential businesses became widespread, many workers were laid off, and unemploy- ment claims spiked, causing a global recession and a sharp fall in equity prices. After markets hit their lowest point of the reporting period in late March 2020, a steady recovery ensued, as businesses began to re-open and governments learned to adapt to life with the virus. Equity prices continued to rise throughout the summer, fed by strong fiscal and monetary support and improving Rob Kapito economic indicators. Many equity indices neared or surpassed all-time highs late in the reporting period President, BlackRock, Inc. following the implementation of mass vaccination campaigns and progress of additional stimulus through the U.S. Congress. In the United States, both large- and small-capitalization stocks posted a significant advance. International equities also gained, as both developed countries and emerging markets re- Total Returns as of February 28, 2021 bounded substantially from lows in late March 2020.
    [Show full text]
  • AGM Notice, to Be Transacted at the Meeting Is Annexed Hereto
    VODAFONE IDEA LIMITED (Formerly Idea Cellular Limited) CIN: L32100GJ1996PLC030976 Registered Office: Suman Tower, Plot No. 18, Sector - 11, Gandhinagar - 382 011, Gujarat Email: [email protected], Website: www.vodafoneidea.com Tel.: + 91-79-66714000 Fax: +91-79-23232251 NOTICE OF THE TWENTY FOURTH ANNUAL GENERAL MEETING NOTICE is hereby given that the Twenty fourth Annual General Meeting of the Members of Vodafone Idea Limited (Formerly Idea Cellular Limited) will be held on Tuesday, the 27th day of August, 2019 at 12:30 p.m. at Cambay Sapphire (Formerly Cambay Spa and Resort), Plot No. 22-24, Near GIDC, Opposite Hillwoods School, Sector 25, Gandhinagar – 382 044, Gujarat, to transact the following business:- ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Standalone Financial Statements and Audited Consolidated Financial Statements for the Financial Year ended March 31, 2019, together with the Reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Himanshu Kapania (DIN: 03387441), who retires by rotation, and being eligible, offers himself for re-appointment. 3. To appoint a Director in place of Mr. Ravinder Takkar (DIN: 01719511), who retires by rotation, and being eligible, offers himself for re-appointment. SPECIAL BUSINESS: 4. Ratification of remuneration payable to Cost Auditors of the Company for FY 2019-20 To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, if any, of the Companies Act, 2013 read with Companies (Audit and Auditors) Rules, 2014 and Companies (Cost Records and Audit) Rules, 2014 (including any statutory modification(s) or re-enactment thereof, for the time being in force), the Company hereby ratifies the remuneration of Rs.
    [Show full text]